Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 87 for “"Ewing sarcoma"”.
-
Heterogeneity in Ewing sarcoma
<p>Ewing sarcoma, an aggressive primary bone and soft tissue tumour is characterised by the expression of the chimeric transcription factor EWS-FLI1 in 90% of patients. This alters expression of many genes including activation of the Insulin Growth Factor (IGF) pathway via IGFBP3 supression. Phase …
-
Ewing sarcoma of the pelvis
… reporting our experience on patients with pelvic Ewing’s Sarcoma treated in the Royal Orthopaedic Oncology Unit. We retrospectively reviewed a series of patients with non-metastatic pelvic Ewing’s sarcoma treated between 1977 and 2009. Patients were classified into three groups according to the …
-
Targeting EWS/FLI1 activity in ewing sarcoma
Ewing sarcoma (ES) is the second most frequent bone cancer in childhood. Clinically, ES appears as very aggressive osteolytic tumor with early tendency for development of metastasis. It belongs to the group of small-round-blue-cell tumors and is comprised of largely undifferentiated cells. The …
-
The Mechanism of Aneuploidy Induction in Ewing Sarcoma
Ewing sarcoma is the second most common bone tumor that arises in adolescence and young adults. Despite tumor resection followed by combined chemotherapy, the recurrence rate of metastasized Ewing sarcoma remains high, displaying a significantly reduced 5-year survival rate compared to patients …
-
Systematic multi-omics profiling of Ewing sarcoma cell lines
100 years after its first description, Ewing sarcoma (EwS), the second most common bone-associated cancer in children and young adults, is still poorly understood. Neither the cell of origin is known, nor the detailed mechanism of expression regulation by the pathognomic fusion oncogene. Similarly, …
-
LOXHD1 IS AN ONCOFUSION-REGULATED ANTIGEN OF EWING SARCOMA
Ewing Sarcoma (EwS) is the second most common malignant bone tumor predominantly affecting children, adolescents, and young adults. The hallmark genetic aberration in EwS is characterized by a unique t(11:22) (q24;q12) translocation resulting in the pathognomonic EWSR1::FLI1 fusion oncoprotein. …
-
Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma
Radboud Universiteit Nijmegen, 22 december 2014
-
Identification of EWS-FLI1 Regions Necessary for Ewing Sarcoma Proliferation
Ewing sarcoma is pediatric bone malignancy defined by a translocation between EWS and ETS family transcription factor. EWS-FLI1 (EF) is the most common translocation and codes for a novel transcription factor that combines the N-terminus of EWS, which contains LC domain comprised of tyrosine rich …
-
Mechanism of action of Viscum album L. extracts in Ewing sarcoma
Ewing sarcoma is the second most common bone cancer in children and adolescents. It has a poor prognosis and outcome. Therefore, drug discovery of new anti-tumor agents is still crucial to improve survival of Ewing sarcoma patients. Combining active substances may be beneficial since some drug …
-
Mutation Evolution and Genomic Patterns of Recurrence in Ewing Sarcoma and Leiomyosarcoma
Sarcomas are a highly heterogeneous group of tumours of the bone and soft tissue whose mutation evolution has been unexplored in the majority of subtypes. From a molecular perspective, sarcomas are sub-classified in two categories: (1) those with disease-defining genetic alterations (commonly …
-
Endoglin in Ewing sarcoma: from the biological relevance to a clinical strategy
… ENG was identified in patient samples from Ewing sarcoma (ES), a bone/soft tissue neoplasia with a putative MSC origin. ES is a predominant paediatric malignancy with high incidence of metastasis at diagnosis, around 30% patients, associated with poor prognosis. This scenario is worsened by …
-
Molecular Characterization of the Ewing Sarcoma Oncoprotein: Functional Interactions and Therapeutic Potential
Ewing sarcoma is an aggressive bone cancer with the driving mutation EWS-FLI1 present in 85% of cases, and the remaining 15% attributed to several other mutations including EWS-ETV1. Critically, the EWS portion of these proteins contains an LC domain, which enables it to undergo LLPS and reversibly …
-
Treatment of Ewing sarcoma family of tumours through the pharmacological activation of p53.
Sarcomas constitute a diverse heterogeneous group of solid bone and soft tissue malignancies of mesenchymal origin. It is estimated that sarcomas account for approximately 15% of all paediatric and 1% of all adult cancers, with 200,000 new cases reported worldwide each year. To date 60 distinct …
-
Understanding Genome Instability in Ewing Sarcoma: from Molecular Mechanisms to Novel Therapeutic Approaches
Ewing sarcoma (EwS) is an aggressive mesenchymal neoplasm mainly occurring in children, adolescents and young adults. It is characterized by fusion proteins involving EWSR1 and a member of the ETS family of transcription factors, mainly FLI1 (85% of the cases). Although 5-year survival for patients …
-
Identifying CDK8/19 as a Novel Regulator of EWS-FLI1 Function in Ewing Sarcoma
Ewing sarcoma, a pediatric bone cancer, is characterized by the translocation of the Low Complexity (LC) domain from an RNA binding protein (EWSR1, FUS, or TAF15) with the DNA binding domain of an ETS transcription factor. The translocation EWS-FLI1 accounts for 90% of Ewing sarcoma tumors and a …
Page 1 of 5